Xin Ye

5.2k total citations · 3 hit papers
77 papers, 3.7k citations indexed

About

Xin Ye is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xin Ye has authored 77 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 45 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Xin Ye's work include Lung Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Xin Ye is often cited by papers focused on Lung Cancer Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Xin Ye collaborates with scholars based in China, United States and Canada. Xin Ye's co-authors include Robert A. Weinberg, Elinor Ng Eaton, Ferenc Reinhardt, Wai Leong Tam, Tsukasa Shibue, Yasemin Kaygusuz, J. Wade Harper, Nissim Hay, Eugene Goufman and Andrei L. Gartel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Xin Ye

70 papers receiving 3.7k citations

Hit Papers

Epithelial–Mesenchymal Plasticity: A Central Regulator of... 2015 2026 2018 2022 2015 2015 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Ye China 17 2.0k 1.8k 851 731 518 77 3.7k
Anushka Dongre United States 11 2.0k 1.0× 1.8k 1.0× 1.2k 1.4× 485 0.7× 764 1.5× 15 3.8k
Sakari Vanharanta United Kingdom 21 2.0k 1.0× 1.6k 0.9× 1.2k 1.4× 552 0.8× 691 1.3× 31 3.7k
Cristina Nadal Spain 17 2.2k 1.1× 2.3k 1.3× 1.3k 1.5× 726 1.0× 475 0.9× 42 4.3k
Adrian M. Jubb United Kingdom 32 2.5k 1.2× 1.6k 0.9× 1.0k 1.2× 630 0.9× 351 0.7× 50 4.0k
Alessia Ciarrocchi Italy 33 2.4k 1.2× 1.2k 0.7× 1.0k 1.2× 639 0.9× 272 0.5× 115 4.0k
Paul H. Huang United Kingdom 31 2.1k 1.0× 1.5k 0.8× 701 0.8× 1.5k 2.0× 316 0.6× 126 4.2k
Zhenhe Suo Norway 32 1.8k 0.9× 1.3k 0.7× 872 1.0× 447 0.6× 273 0.5× 107 3.1k
Baocun Sun China 39 2.8k 1.4× 1.7k 0.9× 1.5k 1.8× 783 1.1× 478 0.9× 145 4.6k
George S. Karagiannis United States 29 1.3k 0.6× 1.3k 0.7× 747 0.9× 374 0.5× 620 1.2× 72 3.3k
Luisa M. Solis United States 28 1.8k 0.9× 831 0.5× 662 0.8× 594 0.8× 306 0.6× 68 2.9k

Countries citing papers authored by Xin Ye

Since Specialization
Citations

This map shows the geographic impact of Xin Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Ye more than expected).

Fields of papers citing papers by Xin Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Ye. The network helps show where Xin Ye may publish in the future.

Co-authorship network of co-authors of Xin Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Ye. A scholar is included among the top collaborators of Xin Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Ye. Xin Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Zhigang, et al.. (2025). Interventional oncology and immunotherapy: current status and future perspectives. Frontiers in Immunology. 16. 1541105–1541105.
2.
Ye, Xin & Xiaoli Ju. (2025). Natural products targeting ferroptosis in cancer: molecular mechanisms and applications. Frontiers in Oncology. 15. 1588668–1588668.
4.
Liu, Nannan, Shanshan Liu, Xin Ye, et al.. (2024). Zinc finger domain of p62/SQSTM1 is involved in the necroptosis of human cisplatin‑resistant ovarian cancer cells treated with sulfasalazine. Oncology Letters. 28(5). 529–529. 1 indexed citations
5.
Wang, Mei‐Xiang, et al.. (2024). Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade. Advanced Science. 12(4). e2413181–e2413181. 3 indexed citations
6.
Li, Jie, Kostas Pantopoulos, Yuqin Liu, et al.. (2024). The clustering status of detached gastric cancer cells inhibits anoikis-induced ferroptosis to promote metastatic colonization. Cancer Cell International. 24(1). 77–77. 4 indexed citations
7.
Wang, Gang, Zhigang Wei, Xiaoying Han, et al.. (2024). Clinical outcomes of percutaneous microwave ablation for pulmonary oligometastases from hepatocellular carcinoma: a retrospective, multicenter study. Cancer Imaging. 24(1). 34–34. 3 indexed citations
8.
Zhou, Jie, Jing Xiang, Guanghui Huang, et al.. (2024). Image-guided percutaneous microwave ablation for unresectable pancreatic cancers: A multicenter retrospective study. European Journal of Radiology. 181. 111720–111720.
10.
Li, Zhichao, Feng Zhao, Gang Wang, et al.. (2023). Changes in the pulmonary function of CT-guided microwave ablation for patients with malignant lung tumors. Journal of Cancer Research and Therapeutics. 19(6). 1669–1674. 11 indexed citations
11.
Zeng, Ziyang, Zhen Liu, Jie Li, et al.. (2023). Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer. Frontiers in Oncology. 12. 1065716–1065716. 3 indexed citations
12.
13.
Han, Cuiping, et al.. (2023). Progress in the knowledge on the transformation of lung adenocarcinoma to small-cell lung cancer. Journal of Cancer Research and Therapeutics. 19(1). 14–19. 6 indexed citations
14.
Yu, Lu, et al.. (2023). Crosstalk between microwave ablation and ferroptosis: The next hot topic?. Frontiers in Oncology. 13. 1099731–1099731. 7 indexed citations
15.
16.
Li, Xin, Yaxi Wang, Xin Ye, & Ping Liang. (2021). Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development. Frontiers in Molecular Biosciences. 8. 635243–635243. 34 indexed citations
17.
Ren, Daixi, Yuze Hua, Boyao Yu, et al.. (2020). Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Molecular Cancer. 19(1). 19–19. 218 indexed citations
18.
Kröger, Cornelia, Alexander B. Afeyan, Elinor Ng Eaton, et al.. (2019). Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells. Proceedings of the National Academy of Sciences. 116(15). 7353–7362. 341 indexed citations breakdown →
19.
Henderson, William R., Y. Emil, Xin Ye, et al.. (2010). Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proceedings of the National Academy of Sciences. 107(32). 14309–14314. 378 indexed citations
20.
Gu, Long-Jun, et al.. (2008). Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells. Chinese Medical Journal. 121(5). 463–468. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026